Based on our previous results, we hypothesize that the current definition of dedifferentiated liposarcoma, characterized by the presence of excess MDM2/CDK4 through amplification or overexpression, encompasses a broad spectrum that may result in varied patient prognoses, therapeutic responses, and chemo-resistance. This evidence concerns the gene CDK4 and liposarcoma.